The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-((6-((Cyanomethyl)carbamoyl)-2-(3,4-dichloro-5-methyl-1H-pyrrole-2-carboxamido)benzo[d]thiazol-4-yl)oxy)ethyl)morpholin-4-ium chloride ID: ALA4876030
PubChem CID: 164627023
Max Phase: Preclinical
Molecular Formula: C22H23Cl3N6O4S
Molecular Weight: 537.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1[nH]c(C(=O)Nc2nc3c(OCCN4CCOCC4)cc(C(=O)NCC#N)cc3s2)c(Cl)c1Cl.Cl
Standard InChI: InChI=1S/C22H22Cl2N6O4S.ClH/c1-12-16(23)17(24)19(27-12)21(32)29-22-28-18-14(34-9-6-30-4-7-33-8-5-30)10-13(11-15(18)35-22)20(31)26-3-2-25;/h10-11,27H,3-9H2,1H3,(H,26,31)(H,28,29,32);1H
Standard InChI Key: RBPRMPXFSQQPIS-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 38 0 0 0 0 0 0 0 0999 V2000
8.8648 -20.8792 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.3119 -19.3768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0283 -18.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0254 -18.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3101 -17.7239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5972 -18.9640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5984 -18.1351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8104 -17.8777 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.3221 -18.5476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8084 -19.2189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5002 -18.5465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0887 -17.8315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2637 -17.8304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5021 -17.1177 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7799 -17.1584 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9949 -17.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9938 -18.2373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7781 -18.4931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3253 -18.7242 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.7383 -17.7178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4544 -18.1277 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7352 -16.8928 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0304 -19.2802 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.3282 -16.9265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3075 -20.2036 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0198 -20.6200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0154 -21.4448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7276 -21.8612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7180 -22.6829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4261 -23.0990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1452 -22.6939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1515 -21.8680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4388 -21.4473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1672 -17.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8832 -18.1222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6001 -18.5298 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 7 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
9 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 13 2 0
17 19 1 0
4 20 1 0
20 21 1 0
20 22 2 0
18 23 1 0
16 24 1 0
2 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
28 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
21 34 1 0
34 35 1 0
35 36 3 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 537.43Molecular Weight (Monoisotopic): 536.0800AlogP: 3.46#Rotatable Bonds: 8Polar Surface Area: 132.37Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.96CX Basic pKa: 6.51CX LogP: 2.55CX LogD: 2.50Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: -2.14
References 1. Durcik M, Nyerges Á, Skok Ž, Skledar DG, Trontelj J, Zidar N, Ilaš J, Zega A, Cruz CD, Tammela P, Welin M, Kimbung YR, Focht D, Benek O, Révész T, Draskovits G, Szili PÉ, Daruka L, Pál C, Kikelj D, Mašič LP, Tomašič T.. (2021) New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens., 213 [PMID:33524686 ] [10.1016/j.ejmech.2021.113200 ]